Preclinical models that illuminate the bone metastasis cascade

Recent Results in Cancer Research

Volumn 192, Issue , 2012, Pages 1-31

  Van Der Horst, Geertje ^a   Van Der Pluijm, Gabri ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLUMINESCENT IMAGING; BONE METASTASIS; BONE TUMOR; CANCER MODEL; CANCER TRANSPLANTATION; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; FLUORESCENT IMAGING; FUNCTIONAL IMAGING; IMAGING SYSTEM; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OPTICAL IMAGING; ORTHOTOPIC TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR XENOGRAFT;

EID: 84858172939     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-21892-7_1     Document Type: Article

References (142)

1. Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7:139-147 (Pubitemid 46160989)
2. An Z, Wang X, Geller J, Moossa AR, Hoffman RM (1998) Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice. Prostate 34:169-174 (Pubitemid 28156606)
3. Arguello F, Baggs RB, Frantz CN (1988) A murine model of experimental metastasis to bone and bone marrow. Cancer Res 48:6876-6881 (Pubitemid 19012221)
4. Asamoto M, Hokaiwado N, Cho YM, Takahashi S, Ikeda Y, Imaida K et al (2001) Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res 61:4693-4700 (Pubitemid 32691878)
5. Bhaumik S, Gambhir SS (2002) Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 99:377-382 (Pubitemid 34060369)
6. Bhowmick NA, Moses HL (2005) Tumor-stroma interactions. Curr Opin Genet Dev 15:97-101 (Pubitemid 40127637)
7. Black PC, Shetty A, Brown GA, Esparza-Coss E, Metwalli AR, Agarwal PK et al (2010) Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis. BJU Int 106:1799-1804
8. Blakely CM, Sintasath L, D'Cruz CM, Hahn KT, Dugan KD, Belka GK et al(2005) Developmental stage determines the effects of MYC in the mammary epithelium. Development 132:1147-1160 (Pubitemid 40484947)
9. Bremer C, Tung CH, Weissleder R (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7:743-748 (Pubitemid 32588033)
10. Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J et al (2011) CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 121:1064-1074
11. Buijs JT, van der Pluijm G (2009) Osteotropic cancers: from primary tumor to bone. Cancer Lett 273:177-193
12. Buijs JT, Rentsch CA, van der Horst G, van Overveld PG, Wetterwald A, Schwaninger R et al (2007a) BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol 171:1047-1057 (Pubitemid 47441001)
13. Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R et al (2007b) Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res 67:8742-8751 (Pubitemid 47437450)
14. Buijs JT, Cheung H, Doumont G, Derksen PW, Jonkers J, van der Pluijm G (2010) A new mouse model of invasive lobular carcinoma of the breast representative of the multi-step process of bone metastasis and minimal residual disease micrometastasis. Bone 47:S282
15. Cao F, Lin S, Xie X, Ray P, Patel M, Zhang X et al (2006) In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113: 1005-1014 (Pubitemid 43879476)
16. Cao F, Drukker M, Lin S, Sheikh AY, Xie X, Li Z et al (2007) Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning Stem Cells 9:107-117 (Pubitemid 46642075)
17. Caysa H, Jacob R, Muther N, Branchini B, Messerle M, Soling A (2009) A redshifted codon-optimized firefly luciferase is a sensitive reporter for bioluminescence imaging. Photochem Photobiol Sci 8:52-56
18. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436:725-730 (Pubitemid 41117277)
19. Coleman RE (1997) Skeletal complications of malignancy. Cancer 80:1588-1594 (Pubitemid 27444031)
20. Contag PR, Olomu IN, Stevenson DK, Contag CH (1998) Bioluminescent indicators in living mammals. Nat Med 4:245-247 (Pubitemid 28137381)
21. Cowey S, Szafran AA, Kappes J, Zinn KR, Siegal GP, Desmond RA et al (2007) Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice. Clin Exp Metastasis 24(5):389-401 (Pubitemid 47124938)
22. D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE et al (2001) c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7:235-239 (Pubitemid 32148492)
23. Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, van Beijnum JR, Griffioen AW, Vink J, Krimpenfort P, Peterse JL, Cardiff RD, Berns A, Jonkers J (2006) Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 105:437-449 (Pubitemid 44693469)
24. Derksen PW, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, Wesseling J et al (2011) Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice. Dis Model Mech 4:347-358
25. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S et al (1996) Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511-12516 (Pubitemid 26160923)
26. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A (2002) In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298:1759-1762 (Pubitemid 35404113)
27. Franzius C, Hotfilder M, Poremba C, Hermann S, Schäfers K, Gabbert HE, Jürgens H, Schober O, Schäfers M, Vormoor J (2006) Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model. Eur J Nucl Med Mol Imaging 33(12):1432-1441 (Pubitemid 44885409)
28. Frese KK, Tuveson DA (2007) Maximizing mouse cancer models. Nat Rev Cancer 7:645-658 (Pubitemid 47327410)
29. Friedl P, Gilmour D (2009) Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10:445-457
30. Futakuchi M, Nannuru KC, Varney ML, Sadanandam A, Nakao K, Asai K et al (2009) Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Sci 100:71-81
31. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M et al (2004) A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 101:17204-17209 (Pubitemid 39627798)
32. Gingrich JR, Greenberg NM (1996) A transgenic mouse prostate cancer model. Toxicol Pathol 24:502-504 (Pubitemid 26274861)
33. Graves EE, Weissleder R, Ntziachristos V (2004) Fluorescence molecular imaging of small animal tumor models. Curr Mol Med 4:419-430 (Pubitemid 38787010)
34. Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB et al (2002) A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J 16:283-292 (Pubitemid 34195290)
35. Henriquez NV, van Overveld PG, Que I, Buijs JT, Bachelier R, Kaijzel EL et al (2007) Advances in optical imaging and novel model systems for cancer metastasis research. Clin Exp Metastasis 24:699-705 (Pubitemid 50000181)
36. Hilderbrand SA, Weissleder R (2010) Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 14:71-79
37. Hinds KA, Hill JM, Shapiro EM, Laukkanen MO, Silva AC, Combs CA et al (2003) Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102:867-872 (Pubitemid 36917777)
38. Hirbe AC, Roelofs AJ, Floyd DH, Deng H, Becker SN, Lanigan LG et al (2009) The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts. Bone 44(5):908-916
39. Hoffman RM (2009) Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins. Clin Exp Metastasis 26:345-355
40. Hynes RO (2007) Cell-matrix adhesion in vascular development. J Thromb Haemost 5(suppl 1): 32-40 (Pubitemid 46964284)
41. Ip C (1996) Mammary tumorigenesis and chemoprevention studies in carcinogen-treated rats. J Mammary Gland Biol Neoplasia 1:37-47
42. Izbicka E, Dunstan CR, Horn D, Harris M, Harris S, Adams R, Mundy GR (1997) Effects of human tumor cell lines on local new bone formation in vivo. Calcif Tissue Int 602:210-215 (Pubitemid 27057509)
43. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM (2003) Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 21:47-51 (Pubitemid 36055826)
44. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A (2001) Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29:418-425 (Pubitemid 34326692)
45. Kalluri R (2009) EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119:1417-1419
46. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428
47. Kaijzel EL, van der Pluijm G, Lowik CW (2007) Whole-body optical imaging in animal models to assess cancer development and progression. Clin Cancer Res 13:3490-3497 (Pubitemid 46955108)
48. Kaijzel EL, Snoeks TJ, Buijs JT, van der Pluijm G, Lowik CW (2009) Multimodal imaging and treatment of bone metastasis. Clin Exp Metastasis 26:371-379
49. Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, Bouvet M (2003) A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113:151-160 (Pubitemid 36999806)
50. Keller ET, Brown J (2004) Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J Cell Biochem 91:718-729
51. Khanna C, Hunter K (2005) Modeling metastasis in vivo. Carcinogenesis 26:513-523 (Pubitemid 41214139)
52. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM et al (2002) Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 99:2884-2889 (Pubitemid 34240555)
53. Kim JB, Stein R, O'Hare MJ (2005) Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis. Tumour Biol 26:173-185 (Pubitemid 41379743)
54. Kim JB, Urban K, Cochran E, Lee S, Ang A, Rice B, et al (2010) Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 5:e9364
55. Kim J, Roh M, Doubinskaia I, Algarroba GN, Eltoum IE, Abdulkadir SA (2011) A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53. Oncogene 20:1-11
56. Korenchuk S, Lehr JE, MClean L, Lee YG, Whitney S, Vessella R et al (2001) VCaP, a cell-based model system of human prostate cancer. In Vivo 15:163-168 (Pubitemid 32328191)
57. Kozloff KM, Weissleder R, Mahmood U (2007) Noninvasive optical detection of bone mineral. J Bone Miner Res 22:1208-1216 (Pubitemid 351339703)
58. Kozloff KM, Quinti L, Patntirapong S, Hauschka PV, Tung CH, Weissleder R et al (2009) Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo. Bone 44:190-198
59. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF et al (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:2290-2293 (Pubitemid 36578497)
60. Kuperwasser C, Dessain S, Bierbaum BE, Garnet D, Sperandio K, Gauvin GP et al (2005) A mouse model of human breast cancer metastasis to human bone. Cancer Res 65:6130-6138 (Pubitemid 40994398)
61. Lakso M, Sauer B, Mosinger B Jr, Lee EJ, Manning RW, Yu SH et al (1992) Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89:6232-6236
62. Lee AS, Tang C, Cao F, Xie X, van der Bogt K, Hwang A et al (2009) Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8:2608-2612
63. Lehr HA, Leunig M, Menger MD, Nolte D, Messmer K (1993) Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 143:1055-1062 (Pubitemid 24070548)
64. Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2:743-755 (Pubitemid 33685572)
65. Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK et al (2005) MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7:485-496 (Pubitemid 40719131)
66. Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545-580 (Pubitemid 36307540)
67. McCabe NP, De S, Vasanji A, Brainard J, Byzova TV (2007) Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. Oncogene 26:6238-6243 (Pubitemid 47414368)
68. McCarthy JR, Bhaumik J, Karver MR, Sibel ES, Weissleder R (2010) Targeted nanoagents for the detection of cancers. Mol Oncol 4:511-528
69. Megason SG, Fraser SE (2007) Imaging in systems biology. Cell 130:784-795 (Pubitemid 47332580)
70. Mueller MM, Fusenig NE (2004) Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839-849 (Pubitemid 39472951)
71. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584-593 (Pubitemid 37328925)
72. Naef F, Huelsken J (2005) Cell-type-specific transcriptomics in chimeric models using transcriptome-based masks. Nucl Acids Res 19:e111
73. Nahrendorf M, Keliher E, Marinelli B, Waterman P, Feruglio PF, Fexon L et al (2010) Hybrid PET-optical imaging using targeted probes. Proc Natl Acad Sci USA 107:7910-7915
74. Nakai M, Mundy GR, Williams PJ, Boyce B, Yoneda T (1992) A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res 52(19):5395-5399
75. Nakamura I, Duong lT, Rodan SB, Rodan GA (2007) Involvement of alphav)beta3 integrins in osteoclast function. J Bone Miner Metab 25:337-344 (Pubitemid 350063834)
76. Nakatsu T, Ichiyama S, Hiratake J, Saldanha A, Kobashi N, Sakata K et al (2006) Structural basis for the spectral difference in luciferase bioluminescence. Nature 440:372-376
77. Nannuru KC, Futakuchi M, Sadanandam A, Wilson TJ, Varney ML, Myers KJ et al (2009) Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis. Clin Exp Metastasis 26:797-808
78. Nannuru KC, Futakuchi M, Varney ML, Vincent TM, Marcusson EG, Singh RK (2010) Matrix metalloproteinase MMP-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface. Cancer Res 70:3494-3504
79. Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML (1999) Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 59:1987-1993 (Pubitemid 29186176)
80. Nicholson B, Theodorescu D (2004) Angiogenesis and prostate cancer tumor growth. J Cell Biochem 91:125-150
81. O'Neill K, Lyons SK, Gallagher WM, Curran KM, Byrne AT (2010) Bioluminescent imaging: a critical tool in pre-clinical oncology research. J Pathol 220:317-327
82. Paget S (1889) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8:98-101
83. Peyruchaud O, Serre CM, NicAmhlaoibh R, Fournier P, Clezardin P (2003) Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J Biol Chem 278:45826-45832 (Pubitemid 37432728)
84. Pollard M (1998) Lobund-Wistar rat model of prostate cancer in man. Prostate 37:1-4 (Pubitemid 28385178)
85. Pollard M, Wolter WR, Sun L (2000) Prostate-seminal vesicle cancers induced in noble rats. Prostate 43:71-74 (Pubitemid 30164246)
86. Power CA, Pwint H, Chan J, Cho J, Yu Y, Walsh W et al (2009) A novel model of bone-metastatic prostate cancer in immunocompetent mice. Prostate 69:1613-1623
87. Pulaski BA, Ostrand-Rosenberg S (2001) Mouse 4T1 breast tumor model. Curr Protoc Immunol Chap. 20:Unit 20.2
88. Reeves K, van der Pluijm G, Cecchini MG, Eaton CL, Hamdy FC, Brown ND (2010) A new in vivo model of prostate cancer metastasis to bone. Bone. 47:S282
89. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH et al (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491-495 (Pubitemid 32098683)
90. Rodriguez-Porcel M, Wu, JC, Gambhir, SS (2009) Molecular imaging of stem cells (July 30, 2009). Stembook (ed) The stem cell research community, stembook. doi:10.3824/stembook. 1.49.1, http://www.stembook.org
91. Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655-1664
92. Rosol TJ, Tannehill-Gregg SH, Corn S, Schneider A, McCauley LK (2004) Animal models of bone metastasis. Cancer Treat Res 18:47-81
93. Rothbauer U, Zolghadr K, Tillib S, Nowak D, Schermelleh L, Gahl A et al (2006) Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat Methods 3:887-889 (Pubitemid 44614722)
94. Santos EB, Yeh R, Lee J, Nikhamin Y, Punzalan B, Punzalan B et al (2009) Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase. Nat Med 15:338-344
95. Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9:493-505 (Pubitemid 46696530)
96. Schroeder T (2008) Imaging stem-cell-driven regeneration in mammals. Nature 453:345-351 (Pubitemid 351693141)
97. Sckell A, Leunig M (2009) The dorsal skinfold chamber: studying angiogenesis by intravital microscopy. Methods Mol Biol 467:305-317
98. Schwaninger R, Rentsch CA, Wetterwald A, van der Horst G, van Bezooijen RL, van der Pluijm G et al (2007) Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases. Am J Pathol 170:160-175 (Pubitemid 47339197)
99. Serganova I, Moroz E, Vider J, Gogiberidze G, Moroz M, Pillarsetty N et al (2009) Multimodality imaging of TGFbeta signaling in breast cancer metastases. FASEB J 23: 2662-2672
100. Shah K, Weissleder R (2005) Molecular optical imaging: applications leading to the development of present day therapeutics. Neuro Rx 2:215-225 (Pubitemid 40471433)
101. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp red fluorescent protein. Nat Biotechnol 22:1567-1572 (Pubitemid 40039460)
102. Shaner NC, Steinbach PA, Tsien RY (2005) A guide to choosing fluorescent proteins. Nat Methods 2:905-909 (Pubitemid 43108726)
103. Shcherbo D, Merzlyak EM, Chepurnykh TV, Fradkov AF, Ermakova GV, Solovieva EA et al (2007) Bright far-red fluorescent protein for whole-body imaging. Nat Methods 4:741-746 (Pubitemid 47338169)
104. Shen Q, Brown PH (2005) Transgenic mouse models for the prevention of breast cancer. Mutat Res 576:93-110 (Pubitemid 40982685)
105. Shtivelman E, Namikawa R (1995) Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue. Proc Natl Acad Sci USA 92:4661-4665
106. Singh M, Johnson L (2006) Using genetically engineered mouse models of cancer to aid drug development: an industry perspective. Clin Cancer Res 12:5312-5328 (Pubitemid 44497244)
107. Snoeks TJ, Lowik CW, Kaijzel EL (2010) 'In vivo' optical approaches to angiogenesis imaging. Angiogenesis 13:135-147
108. Snoeks TJ, Khmelinskii A, Lelieveldt BP, Kaijzel EL, Lowik CW (2011) Optical advances in skeletal imaging applied to bone metastases. Bone 48:106-114
109. Stoica G, Koestner A, Capen CC (1983) Characterization of N-ethyl-N-nitrosourea-induced mammary tumors in the rat. Am J Pathol 110:161-169 (Pubitemid 13147262)
110. Stoica G, Koestner A, Capen CC (1984) Neoplasms induced with high single doses of N-ethyl-N-nitrosourea in 30-day-old Sprague-Dawley rats, with special emphasis on mammary neoplasia. Anticancer Res 4:5-12 (Pubitemid 14113910)
111. Strube A, Stepina E, Mumberg D, Scholz A, Hauff P, Käkönen SM (2010) Characterization of a new renal cell carcinoma bone metastasis mouse model. Clin Exp Metastasis 27(5):319-330
112. Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11:435-443 (Pubitemid 40277320)
113. Tao K, Fang M, Alroy J, Sahagian GG (2008) Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 8:228 Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504-1508
114. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M et al (2000) LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44:91-103 (Pubitemid 30419183)
115. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890
116. Tsien RY (2003) Imagining imaging's future. Nat Rev Mol Cell Biol Suppl:SS16-SS21 (Pubitemid 37082172)
117. Tu WH, Thomas TZ, Masumori N, Bhowmick NA, Gorska AE, Shyr Y et al (2003) The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia 5:267-277 (Pubitemid 36754056)
118. van der Bogt KE, Swijnenburg RJ, Cao F, Wu JC (2006) Molecular imaging of human embryonic stem cells: keeping an eye on differentiation, tumorigenicity and immunogenicity. Cell Cycle 5:2748-2752 (Pubitemid 44901736)
119. van Haperen R, Cheng C, Mees BM, van DE, de Waard M, van Damme LC et al (2003) Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice. Am J Pathol 163:1677-1686 (Pubitemid 37175114)
120. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzman-Ramirez N et al (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70:5163-5173
121. van der Horst G, van Asten JJ, Figdor A, van den Hoogen C, Cheung H, Bevers RF et al (2011a) Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis. Eur Urol 60:337-343
122. van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, Pelger RC et al (2011b) Targeting of alphav)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. Neoplasia 13:516-525
123. van der Pluijm G (2010) Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone 48:37-43
124. van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Lowik C (2001) Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases. J Bone Miner Res 16:1077-1091 (Pubitemid 32467152)
125. van der Pluijm G, Que I, Sijmons B, Buijs JT, Lowik CW, Wetterwald A et al (2005) Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo. Cancer Res 65:7682-7690 (Pubitemid 41297242)
126. Virostko J, Jansen ED (2009) Validation of bioluminescent imaging techniques. Methods Mol Biol 574:15-23
127. Visvader JE (2011) Cells of origin in cancer. Nature 20:314-322
128. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J et al (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209-221 (Pubitemid 37163835)
129. Wang J, Xia TS, Liu XA, Ding Q, Du Q, Yin H et al (2010) A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment. Breast Cancer Res Treat 120:337-344
130. Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452:580-589 (Pubitemid 351483372)
131. Wetterwald A, van der Pluijm G, Que I, Sijmons B, Buijs J, Karperien M et al (2002) Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 160(3):1143-1153 (Pubitemid 34224600)
132. Winter SF, Cooper AB, Greenberg NM (2003) Models of metastatic prostate cancer: a transgenic perspective. Prostate Cancer Prostatic Dis 6:204-211 (Pubitemid 37185147)
133. Xia TS, Wang J, Yin H, Ding Q, Zhang YF, Yang HW et al (2010) Human tissue-specific microenvironment: an essential requirement for mouse models of breast cancer. Oncol Rep 24:203-211
134. Xia TS, Wang GZ, Ding Q, Liu XA, Zhou WB, Zhang YF et al (2011) Bone metastasis in a novel breast cancer mouse model containing human breast and human bone. Breast Cancer Res Treat. 3 Jan 2011 Epub ahead of print
135. Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW et al (1999) Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 3:389-395 (Pubitemid 29290679)
136. Yaghoubi SS, Jensen MC, Satyamurthy N, Budhiraja S, Paik D, Czernin J et al (2009) Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat Clin Pract Oncol 6:53-58
137. Yang M, Li L, Jiang P, Moossa AR, Penman S, Hoffman RM (2003) Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci USA 100:14259-14262 (Pubitemid 37499224)
138. Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K et al (2001) Establishment of a novel species-and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 61:2177-2182 (Pubitemid 32692044)
139. Zaheer A, Lenkinski RE, Mahmood A, Jones AG, Cantley LC, Frangioni JV (2001) In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol 19:1148-1154 (Pubitemid 33115701)
140. Zhang N, Fang Z, Contag PR, Purchio AF, West DB (2004) Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood 103:617-626 (Pubitemid 38140096)
141. Zhang Q, Yin L, Tan Y, Yuan Z, Jiang H (2008) Quantitative bioluminescence tomography guided by diffuse optical tomography. Opt Express 16:1481-1486 (Pubitemid 351239988)
142. Zhou Z, Flesken-Nikitin A, Corney DC, Wang W, Goodrich DW, Roy-Burman P et al (2006) Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 66:7889-7898 (Pubitemid 44299151)